Documents

A list of downloadable documents created during development.

Lymphoma (non-Hodgkin's, refractory, indolent) - idelalisib [ID723]: equality impact assessment scoping form

Lymphoma (non-Hodgkin's, refractory, indolent) - idelalisib: final scope

Lymphoma (non-Hodgkin's, refractory, indolent) - idelalisib: final matrix

Lymphoma (non-Hodgkin's, refractory, indolent) - idelalisib: response to consultee and commentator comments on the draft scope and provisional matrix

Lymphoma (non-Hodgkin's, refractory, indolent) - idelalisib: appendix B - draft scope for consultation (pre-referral) - January 2014

Lymphoma (non-Hodgkin's, refractory, indolent) - idelalisib: appendix C - provisional matrix (pre-referral) - January 2014